OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.
With in-person scientific congresses an impossibility for the foreseeable future, researchers and publishers have to adapt how they foster scientific exchange.
Mike Dixon, CEO of the Healthcare Communications Association, discusses the biggest challenges facing the sector during and after COVID, from digital innovation to talent and sustainability
Pharma has been forced to hold its meetings virtually for most of the year now – but despite having plenty of time to perfect the art of digital engagement, Impetus Digital’s Natalie Yeadon
